|
2021
|
Invention
|
Dispensing device.
A device for dispensing individual doses of powder from respective pockets of... |
|
2020
|
Invention
|
Methods and intermediates for preparing hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-y... |
|
|
Invention
|
Filling head for powered layering of a dry powder inhaler.
A filling head (20) for filling a con... |
|
|
Invention
|
Filling head for powered layering of a dry powder inhaler. A filling head (20) for filling a cont... |
|
2019
|
G/S
|
Pharmaceutical preparations used for stimulating white blood cell production for the treatment of... |
|
|
Invention
|
Process for the preparation of fluticasone propionate form i.
The invention relates to a novel c... |
|
2018
|
Invention
|
Dispensing device. A device for dispensing individual doses of powder from respective pockets of ... |
|
2017
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of cranial and facial nerve disorder... |
|
|
Invention
|
Solid molecular dispersion of fesoterodine hydrogen fumarate and polymeric binder.
The present i... |
|
2016
|
Invention
|
4-(biphen-3-yl)-1h-pyrazolo[3,4-c]pyridazine derivatives of formula (i) as gaba receptor modulato... |
|
|
G/S
|
Pharmaceutical preparations for stimulating white blood cell production |
|
|
Invention
|
Injector |
|
2015
|
G/S
|
Pharmaceutical products; pharmaceuticals for the treatment
of cancer. |
|
|
Invention
|
Sulfonamides derivatives as urat1 inhibitors. The invention relates to sulfonamide derivatives, t... |
|
|
Invention
|
Imidazopyridazine derivatives as modulators of the gabaa receptor activity. The present invention... |
|
|
Invention
|
Imidazopyridazine derivatives as modulators of the gabaa receptor activity.. The present inventio... |
|
|
Invention
|
Chemical compounds.
The present invention relates to imidazopyridazine derivatives. More particu... |
|
|
Invention
|
Chemical compounds.
The present invention relates to new sulfonamide URAT-1 inhibitor compounds ... |
|
|
G/S
|
Pharmaceutical products; pharmaceuticals for the treatment of cancer. |
|
2014
|
Invention
|
Method for producing retinal pigment epithelial cells.
The invention relates to a method for pro... |
|
|
Invention
|
N-acylpiperidine ether tropomyosin-related kinase inhibitors.
The present invention relates to c... |
|
|
Invention
|
N-acylpiperidine ether tropomyosin-related kinase inhibitors. The present invention relates to co... |
|
|
Invention
|
Method for producing retinal pigment epithelial cells. The invention relates to a method for prod... |
|
|
Invention
|
Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors.
The present invention relates to ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auto-immune
diseases and auto-immune disorders. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auto-immune diseases and auto-immune disorders. |
|
|
Invention
|
Chemical compounds. The present invention relates to new sulfonamide URAT-1 inhibitor compounds o... |
|
|
Invention
|
Sulfonamide derivatives as urat-1 inhibitors. The invention relates to sulfonamide derivatives, t... |
|
|
Invention
|
Sulfonamides for the treatment of gout. The invention relates to sulfonamide derivatives, to thei... |
|
2013
|
Invention
|
Chemical compounds. The present invention relates to imidazopyridazine derivatives. More particul... |
|
|
Invention
|
Imidazopyridazine derivatives as gabaa receptor modulators. Chemical Compounds The present invent... |
|
|
Invention
|
Tropomyosin-related kinase inhibitors.
The present invention relates to compounds of Formula (IA... |
|
|
Invention
|
Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors. The present invention relates to co... |
|
|
Invention
|
Pyrrolo[2,3-d]pyrimidine tropomyosin-related kinase inhibitors.
The present invention relates to... |
|
|
Invention
|
Tropomyosin-related kinase inhibitors. The present invention relates to compounds of Formula (IA)... |
|
|
Invention
|
Pyrrolo[2,3-d]pyrimidine tropomyosin-related kinase inhibitors. The present invention relates to ... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders. |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical products. |
|
2012
|
Invention
|
N-aminosulfonyl benzamides.
The present invention relates to sulfonamide derivatives of formula ... |
|
|
Invention
|
Sulfonamide derivatives. The present invention relates to sulfonamide derivatives, of formula (I)... |
|
|
Invention
|
New salt and medical use.
The present invention is directed to 4-[2-(5-amino-1H-pyrazol-4-yl)-4-... |
|
|
Invention
|
(4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators. V1.8 modulato... |
|
|
Invention
|
Process for the preparation of fluticasone propionate form 1. The invention relates to a novel cr... |
|
2011
|
G/S
|
Pharmaceutical preparations and substances; all included in Class 5. |
|
|
G/S
|
Pharmaceutical and veterinary products, particularly anti-cancer preparations. |
|
2008
|
G/S
|
Pharmaceutical preparations; pharmaceuticals used for
stimulating white blood cell production; p... |
|
2006
|
G/S
|
Anti-cancer products. |
|
2003
|
G/S
|
Pharmaceutical preparations and substances for use in cancer therapy. |
|
1991
|
G/S
|
Pharmaceutical preparations for the prevention and/or treatment of tumours of any description; an... |
